Update in Diagnosis and Treatment of Chronic Pelvic Pain Syndromes

被引：1
作者：
Shah N. [1 ]
Ginzburg N. [1 ]
Morrissey D. [1 ]
Whitmore K. [2 ]
机构：
[1] Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, Drexel University College of Medicine, 207 North Broad St, 4th floor, Philadelphia, 19107, PA
[2] Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, Drexel University College of Medicine, Pelvic and Sexual Health Institute, 207 North Broad St, 4th floor, Philadelphia, 19107, PA
来源：
Current Bladder Dysfunction Reports | 2015年 / 10卷 / 3期
关键词：
Chronic pelvic pain; Chronic prostatitis; Interstitial cystitis; Pelvic floor dysfunction; Sexual dysfunction; Vulvar pain disorder;
D O I：
10.1007/s11884-015-0302-y
中图分类号：
学科分类号：
摘要：
The diagnosis and treatment of chronic pelvic pain have shifted from organ-specific to multifactorial, multidisciplinary, and individualized approach. While many organizations have had diverse outlooks on classification and treatment plans, new research has identified varied clinical phenotypes and updated classification systems. These phenotypes are based on pain, gender, symptomatology, and comorbid pain syndromes. These new classification systems allow a multimodal therapeutic approach and evaluation of patients. Multidisciplinary care, including urology, gynecology, gastroenterology, neurology, psychology, physiotherapy, and pain medicine, is also further recognized for adequate management of patients with chronic pelvic pain because of its variable etiology. The purpose of this review is to emphasize these changes and discuss management strategies. © 2015, Springer Science+Business Media New York.
引用
收藏
页码：198 / 206
页数：8
相关论文
共 91 条
  • [1] Nickel J.C., Et al., Update on urologic pelvic pain syndromes, Rev Urol, 13, 1, pp. 39-49, (2011)
  • [2] Hanno P., Et al., Bladder Pain Syndrome Committee of the International Consultation on Incontinence, Neurourol Urodyn, 29, 1, pp. 191-198, (2010)
  • [3] Engeler D.S., Et al., The 2013 EAU guidelines on chronic pelvic pain: is management of chronic pelvic pain a habit, a philosophy, or a science? 10 years of development, Eur Urol, 64, 3, pp. 431-439, (2013)
  • [4] Clemens J.Q., Et al., The MAPP research network: a novel study of urologic chronic pelvic pain syndromes, BMC Urol, 14, (2014)
  • [5] Shoskes D.A., Et al., Clinical phenotyping in chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis: a management strategy for urologic chronic pelvic pain syndromes, Prostate Cancer Prostatic Dis, 12, 2, pp. 177-183, (2009)
  • [6] Nickel J.C., Shoskes D.A., Irvine-Bird K., Clinical phenotyping of women with interstitial cystitis/painful bladder syndrome: a key to classification and potentially improved management, J Urol, 182, 1, pp. 155-160, (2009)
  • [7] Konkle K.S., Et al., Comparison of an interstitial cystitis/bladder pain syndrome clinical cohort with symptomatic community women from the RAND Interstitial Cystitis Epidemiology study, J Urol, 187, 2, pp. 508-512, (2012)
  • [8] Gamper M., Are mast cells still good biomarkers for bladder pain syndrome/interstitial cystitis?, J Urol, 193, 6, pp. 1994-2000, (2015)
  • [9] Russell A.L., Glycoaminoglycan (GAG) deficiency in protective barrier as an underlying, primary cause of ulcerative colitis, Crohn’s disease, interstitial cystitis and possibly Reiter’s syndrome, Med Hypotheses, 52, 4, pp. 297-301, (1999)
  • [10] Logadottir Y., Et al., Inflammation characteristics in bladder pain syndrome ESSIC type 3C/classic interstitial cystitis, Int J Urol, 21, pp. 75-78, (2014)
12345678910